BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 18181969)

  • 1. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
    Gilbert SC; Klintmalm G; Menter A; Silverman A
    Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
    Mathew J; Leong MY; Morley N; Burt AD
    BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
    Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
    J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-induced liver cirrhosis in a patient of psoriasis.
    Avasthi G; Bhatt P; Singh J
    J Assoc Physicians India; 2012 May; 60():47-8. PubMed ID: 23029724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
    Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
    Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
    Langman G; Hall PM; Todd G
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H
    Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
    [No Abstract]   [Full Text] [Related]  

  • 16. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
    Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
    Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and Chang liver cell cytotoxic studies of methotrexate-treated psoriatic patients with liver cirrhosis.
    Thestrup-Pedersen K; Laurberg G; Søgaard H; Rønnevig JR
    Acta Derm Venereol; 1988; 68(1):74-7. PubMed ID: 2449016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
    Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic arthritis: clinical response and side effects to methotrexate therapy.
    Espinoza LR; Zakraoui L; Espinoza CG; Gutiérrez F; Jara LJ; Silveira LH; Cuéllar ML; Martínez-Osuna P
    J Rheumatol; 1992 Jun; 19(6):872-7. PubMed ID: 1404123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H; Schrøder H; Foged E; Søgaard H
    Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.